Skip to content
2000
Volume 21, Issue 4
  • ISSN: 1573-398X
  • E-ISSN: 1875-6387

Abstract

Obstructive Sleep Apnea (OSA) is identified by repetitive airway obstruction while sleeping, which affects decreased oxygen levels and fragmented sleeping. Structural contributors include a small jaw, enlarged adenoids, Down syndrome, and a low hyoid bone. Non-structural risk factors are obesity, older age, male sex, alcohol use, smoking, and neurological disorders. OSA is diagnosed based on obstructive respiratory events during sleep. Chronic Obstructive Pulmonary Disease (COPD) encompasses the chronic emphysema and bronchitis. Both are marked by persistent symptoms that significantly impact respiratory function. Chronic bronchitis can be identified by a long-term cough along with the production of mucus, while emphysema involves the gradual destruction of the air sacs in the lungs, leading to difficulty in breathing. Together, these conditions result in ongoing shortness of breath, reduced airflow, and a decreased ability to perform everyday activities, severely affecting life for those affected patients. “Overlap syndrome” refers to the coexistence of COPD and OSA. In these patients, sleep worsens breathing difficulties, leading to significant oxygen desaturation, especially during REM sleep. This results from airway obstructions and reduced respiratory drive, with factors like smoking and corticosteroid use exacerbating the condition.

Loading

Article metrics loading...

/content/journals/crmr/10.2174/011573398X354337250214104212
2025-02-17
2026-01-07
Loading full text...

Full text loading...

References

  1. ManninoD.M. GagnonR.C. PettyT.L. LydickE. Obstructive lung disease and low lung function in adults in the united states: Data from the national health and nutrition examination survey, 1988-1994.Arch. Intern. Med.2000160111683168910.1001/archinte.160.11.168310847262
    [Google Scholar]
  2. YoungT. PaltaM. DempseyJ. SkatrudJ. WeberS. BadrS. The occurrence of sleep-disordered breathing among middle-aged adults.N. Engl. J. Med.1993328171230123510.1056/NEJM1993042932817048464434
    [Google Scholar]
  3. MarinJ.M. SorianoJ.B. CarrizoS.J. BoldovaA. CelliB.R. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: The overlap syndrome.Am. J. Respir. Crit. Care Med.2010182332533110.1164/rccm.200912‑1869OC20378728
    [Google Scholar]
  4. RyanS. TaylorC.T. McNicholasW.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.Circulation2005112172660266710.1161/CIRCULATIONAHA.105.55674616246965
    [Google Scholar]
  5. KendzerskaT. LeungR.S. AaronS.D. AyasN. SandozJ.S. GershonA.S. Cardiovascular outcomes and all-cause mortality in patients with obstructive sleep apnea and chronic obstructive pulmonary disease (overlap syndrome).Ann. Am. Thorac. Soc.2019161718110.1513/AnnalsATS.201802‑136OC30372124
    [Google Scholar]
  6. SlowikJ.M. SankariA. CollenJ.F. Obstructive sleep apnea.StatPearls Publishing20241629083619
    [Google Scholar]
  7. RundoJ.V. Obstructive sleep apnea basics.Cleve. Clin. J. Med.2019869 (Suppl 1)2910.3949/ccjm.86.s1.0231509498
    [Google Scholar]
  8. GarveyJ.F. PengoM.F. DrakatosP. KentB.D. Epidemiological aspects of obstructive sleep apnea.J. Thorac. Dis.20157592092910.3978/j.issn.2072‑1439.2015.04.5226101650
    [Google Scholar]
  9. BerryR. B. BrooksR. GamaldoC. Aasm scoring manual updates for 2017 (version 2.4).J. Clin. Sleep. Med.201713566566610.5664/jcsm.657628416048
    [Google Scholar]
  10. DevineJ.F. Chronic obstructive pulmonary disease: An overview.Am. Health Drug Benefits.200817344225126252
    [Google Scholar]
  11. BautersF. RietzschelE.R. HertegonneK.B.C. ChirinosJ.A. The link between obstructive sleep apnea and cardiovascular disease.Curr. Atheroscler. Rep.201618111110.1007/s11883‑015‑0556‑z26710793
    [Google Scholar]
  12. ZhouY. YanM. YuanJ. WangY. QiaoS. Continuous positive airway pressure treatment decreases the risk of atrial fibrillation recurrence in patients with obstructive sleep apnea after radiofrequency ablation.Int. Heart J.202263471672110.1536/ihj.22‑12935831157
    [Google Scholar]
  13. PauwelsR.A. BuistA.S. CalverleyP.M.A. JenkinsC.R. HurdS.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. nhlbi/who global initiative for chronic obstructive lung disease (gold) workshop summary.Am. J. Respir. Crit. Care Med.200116351256127610.1164/ajrccm.163.5.210103911316667
    [Google Scholar]
  14. StollerJ.K. FromerL. BrantlyM. StocksJ. StrangeC. Primary care diagnosis of alpha-1 antitrypsin deficiency: Issues and opportunities.Cleve. Clin. J. Med.2007741286987410.3949/ccjm.74.12.86918183837
    [Google Scholar]
  15. CelliB.R. MacNeeW. AgustiA. AnzuetoA. BergB. BuistA.S. CalverleyP.M.A. ChavannesN. DillardT. FahyB. FeinA. HeffnerJ. LareauS. MeekP. MartinezF. McNicholasW. MurisJ. AustegardE. PauwelsR. RennardS. RossiA. SiafakasN. TiepB. VestboJ. WoutersE. ZuWallackR. ATS/ERS Task Force Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper.Eur. Respir. J.200423693294610.1183/09031936.04.0001430415219010
    [Google Scholar]
  16. LacyP. LeeJ.L. VethanayagamD. Sputum analysis in diagnosis and management of obstructive airway diseases.Ther. Clin. Risk Manag.20051316917918360557
    [Google Scholar]
  17. RabeK.F. HurdS. AnzuetoA. BarnesP.J. BuistS.A. CalverleyP. FukuchiY. JenkinsC. Rodriguez-RoisinR. van WeelC. ZielinskiJ. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.Am. J. Respir. Crit. Care Med.2007176653255510.1164/rccm.200703‑456SO17507545
    [Google Scholar]
  18. DurheimM.T. HolmesD.N. BlancoR.G. AllenL.A. ChanP.S. FreemanJ.V. FonarowG.C. GoA.S. HylekE.M. MahaffeyK.W. PokorneyS.D. ReiffelJ.A. SingerD.E. PetersonE.D. PicciniJ.P. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.Heart2018104221850185810.1136/heartjnl‑2017‑31273529875139
    [Google Scholar]
  19. MaclayJ.D. McAllisterD.A. RabinovichR. HaqI. MaxwellS. HartlandS. ConnellM. MurchisonJ.T. van BeekE.J.R. GrayR.D. MillsN.L. MacNeeW. Systemic elastin degradation in chronic obstructive pulmonary disease.Thorax201267760661210.1136/thoraxjnl‑2011‑20094922374923
    [Google Scholar]
  20. CelliB.R. HalbertR.J. IsonakaS. SchauB. Population impact of different definitions of airway obstruction.Eur. Respir. J.200322226827310.1183/09031936.03.0007510212952259
    [Google Scholar]
  21. TufikS. Santos-SilvaR. TaddeiJ.A. BittencourtL.R.A. Obstructive sleep apnea syndrome in the sao paulo epidemiologic sleep study.Sleep Med.201011544144610.1016/j.sleep.2009.10.00520362502
    [Google Scholar]
  22. PeppardP.E. YoungT. BarnetJ.H. PaltaM. HagenE.W. HlaK.M. Increased prevalence of sleep-disordered breathing in adults.Am. J. Epidemiol.201317791006101410.1093/aje/kws34223589584
    [Google Scholar]
  23. McNicholasW.T. Chronic obstructive pulmonary disease and obstructive sleep apnoea-the overlap syndrome.J. Thorac. Dis.20168223624210.3978/j.issn.2072‑1439.2016.01.5226904264
    [Google Scholar]
  24. ZamarrónC. PazGV. MoreteE. MatíasCF. Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences.Int. J. Chron. Obstruct. Pulmon. Dis.20083467168210.2147/COPD.S495019281082
    [Google Scholar]
  25. WhiteL.H. BradleyT.D. Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea.J. Physiol.201359151179119310.1113/jphysiol.2012.24515923230237
    [Google Scholar]
  26. McNicholasW.T. Chronic obstructive pulmonary disease and obstructive sleep apnea: Overlaps in pathophysiology, systemic inflammation, and cardiovascular disease.Am. J. Respir. Crit. Care Med.2009180869270010.1164/rccm.200903‑0347PP19628778
    [Google Scholar]
  27. DeeganP.C. McNicholasW.T. Pathophysiology of obstructive sleep apnoea.Eur. Respir. J.1995871161117810.1183/09031936.95.080711617589402
    [Google Scholar]
  28. VerbraeckenJ. McNicholasW.T. Respiratory mechanics and ventilatory control in obesity hypoventilation and overlap syndrome.Minerva Pneumol.201150317719210.1186/1465‑9921‑14‑13224256627
    [Google Scholar]
  29. PoulainM. DoucetM. MajorG.C. The effect of obesity on chronic respiratory diseases: Pathophysiology and therapeutic strategies.CMAJ.200617491293129910.1503/cmaj.05129916636330
    [Google Scholar]
  30. ChaouatA. WeitzenblumE. KesslerR. CharpentierC. EhrhartM. Levi-ValensiP. ZielinskiJ. DelaunoisL. CornudellaR. Moutinho dos SantosJ. Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia.Eur. Respir. J.19971081730173510.1183/09031936.97.100817309272911
    [Google Scholar]
  31. StevelingE.H. ClarenbachC.F. MiedingerD. EnzC. DürrS. MaierS. SieviN. ZoggS. LeuppiJ.D. KohlerM. Predictors of the overlap syndrome and its association with comorbidities in patients with chronic obstructive pulmonary disease.Respiration201488645145710.1159/00036861525472034
    [Google Scholar]
  32. McNicholasW.T. Diagnosis of obstructive sleep apnea in adults.Proc. Am. Thorac. Soc.20085215416010.1513/pats.200708‑118MG18250207
    [Google Scholar]
  33. McNicholasW.T. CalverleyP.M.A. LeeA. EdwardsJ.C. Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD.Eur. Respir. J.200423682583110.1183/09031936.04.0008580415218993
    [Google Scholar]
  34. RyanS. DohertyL.S. RockC. NolanG.M. McNicholasW.T. Effects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary disease.Respiration201079647548110.1159/00023561919684384
    [Google Scholar]
  35. SampolG. SagalésM.T. RocaA. de la CalzadaM.D. BofillJ.M. MorellF. Nasal continuous positive airway pressure with supplemental oxygen in coexistent sleep apnoea-hypopnoea syndrome and severe chronic obstructive pulmonary disease.Eur. Respir. J.19969111111610.1183/09031936.96.090101118834343
    [Google Scholar]
/content/journals/crmr/10.2174/011573398X354337250214104212
Loading
/content/journals/crmr/10.2174/011573398X354337250214104212
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test